Article Versions Notes

Smeets EMM, Dorst DN, Franssen GM, van Essen MS, Frielink C, Stommel MWJ, Trajkovic-Arsic M, Cheung PF, Siveke JT, Wilson I, et al. Fibroblast Activation Protein-Targeting Minibody-IRDye700DX for Ablation of the Cancer-Associated Fibroblast with Photodynamic Therapy. Cells. 2023; 12(10):1420. https://doi.org/10.3390/cells12101420

Smeets, Esther M. M., Daphne N. Dorst, Gerben M. Franssen, Merijn S. van Essen, Cathelijne Frielink, Martijn W. J. Stommel, Marija Trajkovic-Arsic, Phyllis F. Cheung, Jens T. Siveke, Ian Wilson, and et al. 2023. "Fibroblast Activation Protein-Targeting Minibody-IRDye700DX for Ablation of the Cancer-Associated Fibroblast with Photodynamic Therapy" Cells 12, no. 10: 1420. https://doi.org/10.3390/cells12101420

Smeets, E. M. M., Dorst, D. N., Franssen, G. M., van Essen, M. S., Frielink, C., Stommel, M. W. J., Trajkovic-Arsic, M., Cheung, P. F., Siveke, J. T., Wilson, I., Mascioni, A., Aarntzen, E. H. J. G., & van Lith, S. A. M. (2023). Fibroblast Activation Protein-Targeting Minibody-IRDye700DX for Ablation of the Cancer-Associated Fibroblast with Photodynamic Therapy. Cells, 12(10), 1420. https://doi.org/10.3390/cells12101420